• Patient-Derived Gastric Cancer Assembloids

  2026-08-18

  This study introduces patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations, providing a more physiologically relevant model of tumor heterogeneity and microenvironmental signaling. The system revealed stromal regulation of gene expression and drug sensitivity, supporting its use for resistance studies and individualized therapeutic testing.

• Tofacitinib Citrate: Applied JAK-STAT Workflows

  2026-08-18

  Tofacitinib citrate enables controlled studies of JAK-STAT signaling, lymphocyte proliferation, and Th1, Th2, and Th17 differentiation. Its value extends beyond immune assays: carefully tiered dosing can reveal why cytokine suppression does not always predict endothelial protection in inflammatory disorder research.

• Carvedilol Phosphate for Reproducible Cell Assays

  2026-08-17

  Learn how Carvedilol Phosphate, SKU C6404, can support better-controlled viability, proliferation, and GPCR-signaling experiments. This scenario-driven guide covers solvent selection, assay controls, ischemia–reperfusion interpretation, and practical supplier evaluation.

• Berberine Hydrochloride: AMPK Research Workflows

  2026-08-17

  Build reproducible Berberine hydrochloride experiments around AMPK signaling, LDLR expression, lipid metabolism, and cancer-cell stress responses. This workflow also translates mitochondrial assay logic from a cardiotoxicity study into practical controls without overstating evidence across models.

• Annexin V-Cy5 Apoptosis Kit: 5 Lab Scenarios

  2026-08-16

  This scenario-based guide explains how Annexin V-Cy5 Apoptosis Kit SKU K2005 supports rapid phosphatidylserine-based apoptosis assessment in microscopy and flow cytometry. It also shows how to distinguish cell death from lysosomal stress, optimize handling, and select a practical fluorescent assay for biomedical and cancer research.

• Capsaicin: TRPV1 and KDM1A Research Workflows

  2026-08-15

  Capsaicin is a versatile research tool for separating TRPV1-driven sensory responses from KDM1A-dependent cancer phenotypes. This workflow-focused guide covers dose selection, calcium assays, gastric cancer studies, chronic dermatitis models, and troubleshooting for reproducible translational experiments.

• Streptavidin Magnetic Beads for HBV Entry Assays

  2026-08-14

  Discover how streptavidin magnetic beads can turn the CDC42–NTCP–macropinocytosis model of HBV entry into more discriminating capture assays. This guide combines mechanistic virology, low-background bead chemistry, and practical workflow design for biotinylated targets.

• Maternal IL-17A Predicts Neonatal GBS Risk

  2026-08-14

  A prospective Moroccan mother–newborn study found that reduced maternal IL-17A, IL-1β, and IL-4 responses among GBS-colonized women were associated with invasive neonatal disease. The work positions circulating maternal IL-17A as a potential risk-stratification biomarker and links clinical outcomes with ex vivo TLR1/2 and TLR4 stimulation data.

• EdU Flow Cytometry Assay Kits (Cy3) Workflow

  2026-08-13

  EdU Flow Cytometry Assay Kits (Cy3) convert a short DNA-synthesis pulse into a quantitative flow-cytometry readout without harsh DNA denaturation. This workflow guide shows how to apply the assay to LUAD drug studies, cell-cycle profiling, genotoxicity testing, and multiplexed biomarker experiments while controlling the variables that most often compromise reproducibility.

• MK 0893: Glucagon Receptor Antagonist Workflows

  2026-08-13

  MK 0893 enables nanomolar interrogation of GCGR binding, cAMP signaling, and glucagon-driven glucose regulation. This practical guide connects receptor pharmacology with cell-based, selectivity, and in vivo workflows while highlighting controls that improve assay reproducibility.

• Methoxy-X04 Workflows for Amyloid Imaging

  2026-08-12

  Methoxy-X04 converts amyloid pathology into an actionable fluorescent readout for tissue, vascular, and in vivo Alzheimer's disease research. This workflow-focused guide shows how to pair plaque imaging with microglial and extracellular-vesicle experiments, while separating genuine biological changes from probe, timing, and optical artifacts.

• Sitagliptin phosphate monohydrate Workflows

  2026-08-12

  Sitagliptin phosphate monohydrate provides a practical DPP-4 inhibition tool for separating endogenous incretin effects from intestinal mechanosensation. This workflow connects biochemical potency, GLP-1 and GIP measurements, oral glucose tolerance, and obesity-related satiety phenotypes without assuming that every metabolic response is GLP-1 dependent.

• Neurotensin: Designing Better NTR1 Assays

  2026-08-11

  Neurotensin is a versatile Neurotensin receptor 1 activator for connecting GPCR signaling with receptor trafficking and miR-133α modulation. This assay-design guide adds a critical spectral-quality framework, showing how interference controls and analytical preprocessing can strengthen gastrointestinal cell studies.

• (-)-Blebbistatin in Cardiac Opto-Mechanics

  2026-08-11

  (-)-Blebbistatin is a selective non-muscle myosin II inhibitor for separating cytoskeletal mechanics from cardiac electrical behavior. This guide shows how to combine its reversible actomyosin perturbation with panoramic opto-electrical mapping to design more interpretable cardiac and cell-mechanics assays.

• PD0325901: MEK Inhibition in Cancer Research

  2026-08-10

  PD0325901 is a selective MEK inhibitor that reduces phosphorylated ERK and suppresses tumor growth in selected mouse xenograft models. Its research value includes pathway interrogation, cell-cycle analysis, apoptosis induction in cancer cells, and comparison of MEK-dependent phenotypes with emerging TERT-regulation biology.

15269 records 1/1018 page Next 12345 下5页 Last page